8th EGA Legal Affairs Forum

The European Generics Association will be hosting the 8th EGA Legal Affairs Forum between the 22 and 23 March 2012 in Brussels.

It will feature an interesting programme including:

Recent developments on SPCs:
• SPCs caselaw and legislation update

  • – The galanthamine and the memantine decisions
  • – The Medeva and the Georgetown references to the CJEU
  • – Paediatric extensions: negative term SPCs

• Combination products in the pipeline

  • – the effect of the Medeva judgment

• Litigating SPCs around Europe – escitalopram case study

  • – What is the product/active ingredient? Regulatory and litigation strategies

• Roundtable presentations on national escitalopram SPC cases: Germany, France, The Netherlands, Belgium
Maximising legal professional privilege:
• Privilege in litigation in Europe
(General overview, comparing approach in different Member States)
• Privilege and European Commission investigations/patent settlement cases
(The Akzo Nobel case, practical issues arising from investigations – privilege and disclosure, update on the Commission’s investigations into patent settlements)
Patent enforcement in Europe:

  • Views on the review of Directive 2004/48/EC on the enforcement of IP rights
  • Views on the changes in the EU patent system: single court and patent with unitary effect
  • Update on court cases that impact the industry

The Full Programme can be found here and it starts with a welcome buffet lunch sponsored by Bird & Bird.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.